Literature DB >> 10763915

Minimal liver resection strongly stimulates the growth of human colon cancer in the liver of nude mice.

B Rashidi1, Z An, F X Sun, A Sasson, R Gamagammi, A R Moossa, R M Hoffman.   

Abstract

Partial hepatectomy has been widely employed in clinical practice as the therapy of choice for primary and metastatic liver tumors. However, the recurrence rate after the treatment remains high, which is most likely due to the growth of residual microscopic lesions. Previous studies in murine models demonstrated that a 70% hepatectomy significantly accelerated the growth of ectopically implanted tumors. In this study, we reported the effect of partial hepatectomy on the growth of two human colon cancers (Co-3 and AC3603) implanted in the liver of nude mice using the technique of surgical implantation of histologically intact tumor tissue. Our results showed a dramatic acceleration of tumor growth following 30% partial hepatectomy, which resembles clinical procedures. Tumor volumes were assessed with calipers on day-15 by abdominal palpation and on day-30 at autopsy by direct measurement. For both Co-3 and AC3603, tumor volumes in the hepatectomized animals were significantly larger than the control at the above two time points (P < 0.001). The results demonstrate the stimulating effect of partial hepatectomy directly on the tumor growth in the liver, in contrast to previous studies on ectopic tumors. Furthermore, since conservative partial hepatectomy (30%) is normally used in clinical practice for surgical treatment of liver metastasis, the animal models presented here should be useful for the clinical investigation of the high recurrence rate of liver metastasis following partial hepatectomy.

Entities:  

Mesh:

Year:  1999        PMID: 10763915     DOI: 10.1023/a:1006693224835

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  17 in total

1.  Tumor growth in partially hepatectomized rats.

Authors:  K E PASCHKIS; A CANTAROW; J STASNEY; J H HOBBS
Journal:  Cancer Res       Date:  1955-10       Impact factor: 12.701

2.  Human RT-4 bladder carcinoma is highly metastatic in nude mice and comparable to ras-H-transformed RT-4 when orthotopically onplanted as histologically intact tissue.

Authors:  X Fu; R M Hoffman
Journal:  Int J Cancer       Date:  1992-07-30       Impact factor: 7.396

3.  Extensive multi-organ metastasis following orthotopic onplantation of histologically-intact human bladder carcinoma tissue in nude mice.

Authors:  X Y Fu; D Theodorescu; R S Kerbel; R M Hoffman
Journal:  Int J Cancer       Date:  1991-12-02       Impact factor: 7.396

4.  Partial hepatectomy augments the liver's antitumor response.

Authors:  R Doerr; M Castillo; P Evans; N Paolini; M Goldrosen; S A Cohen
Journal:  Arch Surg       Date:  1989-02

5.  Dying and regeneration of human tumor cells after heterotransplantation to athymic mice.

Authors:  P Köpf-Maier
Journal:  Histol Histopathol       Date:  1986-10       Impact factor: 2.303

6.  Surgical orthotopic implantation allows high lung and lymph node metastatic expression of human prostate carcinoma cell line PC-3 in nude mice.

Authors:  Z An; X Wang; J Geller; A R Moossa; R M Hoffman
Journal:  Prostate       Date:  1998-02-15       Impact factor: 4.104

7.  Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence.

Authors:  K S Hughes; R Simon; S Songhorabodi; M A Adson; D M Ilstrup; J G Fortner; B J Maclean; J H Foster; J M Daly; D Fitzherbert
Journal:  Surgery       Date:  1986-08       Impact factor: 3.982

8.  Nude mouse metastatic models of human stomach cancer constructed using orthotopic implantation of histologically intact tissue.

Authors:  T Furukawa; X Fu; T Kubota; M Watanabe; M Kitajima; R M Hoffman
Journal:  Cancer Res       Date:  1993-03-01       Impact factor: 12.701

9.  Augmentation of mouse natural killer cell activity by a streptococcal preparation, OK-432.

Authors:  K Oshimi; S Kano; F Takaku; K Okumura
Journal:  J Natl Cancer Inst       Date:  1980-12       Impact factor: 13.506

10.  Characterisation of the vasculature within a murine adenocarcinoma growing in different sites to evaluate the potential of vascular therapies.

Authors:  S E Cowen; M C Bibby; J A Double
Journal:  Acta Oncol       Date:  1995       Impact factor: 4.089

View more
  8 in total

Review 1.  Liver regeneration and tumor stimulation--a review of cytokine and angiogenic factors.

Authors:  Christopher Christophi; Nadia Harun; Theodora Fifis
Journal:  J Gastrointest Surg       Date:  2008-01-08       Impact factor: 3.452

2.  A highly metastatic Lewis lung carcinoma orthotopic green fluorescent protein model.

Authors:  B Rashidi; M Yang; P Jiang; E Baranov; Z An; X Wang; A R Moossa; R M Hoffman
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

3.  Parenchyma-preserving hepatic resection for colorectal liver metastases.

Authors:  Maximilian von Heesen; Jochen Schuld; Jens Sperling; Frank Grünhage; Frank Lammert; Sven Richter; Martin K Schilling; Otto Kollmar
Journal:  Langenbecks Arch Surg       Date:  2011-11-17       Impact factor: 3.445

4.  Major but not minor hepatectomy accelerates engraftment of extrahepatic tumor cells.

Authors:  Kathrin Rupertus; Otto Kollmar; Claudia Scheuer; Bastian Junker; Michael D Menger; Martin K Schilling
Journal:  Clin Exp Metastasis       Date:  2007-01-27       Impact factor: 5.150

5.  Curative in situ ablation of colorectal liver metastases-experimental and clinical implementation.

Authors:  Christoph Isbert; Heinz J Buhr; Joerg-Peter Ritz; W Hohenberger; Christoph-T Germer
Journal:  Int J Colorectal Dis       Date:  2006-11-28       Impact factor: 2.571

Review 6.  Tumour progression and liver regeneration--insights from animal models.

Authors:  Chetana Lim; Francois Cauchy; Daniel Azoulay; Olivier Farges; Maxime Ronot; Marc Pocard
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-04-09       Impact factor: 46.802

7.  Evaluation of safety for hepatectomy in a novel mouse model with nonalcoholic-steatohepatitis.

Authors:  Yusuke Ozawa; Takafumi Tamura; Yohei Owada; Yoshio Shimizu; Akira Kemmochi; Katsuji Hisakura; Takashi Matsuzaka; Hitoshi Shimano; Hiroko Isoda; Nobuhiro Ohkohchi
Journal:  World J Gastroenterol       Date:  2018-04-21       Impact factor: 5.742

Review 8.  Colorectal Cancer: The Contribution of CXCL12 and Its Receptors CXCR4 and CXCR7.

Authors:  Aïssata Aimée Goïta; Dominique Guenot
Journal:  Cancers (Basel)       Date:  2022-04-02       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.